- Home
- LENZ vs ESRT Comparison
LENZ vs ESRT Comparison
Compare LENZ & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- ESRT
- Stock Information
- Founded
- LENZ 2019
- ESRT 2011
- Country
- LENZ United States
- ESRT United States
- Employees
- LENZ N/A
- ESRT N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- ESRT Real Estate Investment Trusts
- Sector
- LENZ Health Care
- ESRT Real Estate
- Exchange
- LENZ Nasdaq
- ESRT Nasdaq
- Market Cap
- LENZ 1.2B
- ESRT 1.2B
- IPO Year
- LENZ 2021
- ESRT 2013
- Fundamental
- Price
- LENZ $31.84
- ESRT $8.03
- Analyst Decision
- LENZ Strong Buy
- ESRT Hold
- Analyst Count
- LENZ 4
- ESRT 2
- Target Price
- LENZ $56.25
- ESRT $10.65
- AVG Volume (30 Days)
- LENZ 1.2M
- ESRT 1.7M
- Earning Date
- LENZ 11-05-2025
- ESRT 10-29-2025
- Dividend Yield
- LENZ N/A
- ESRT 1.75%
- EPS Growth
- LENZ N/A
- ESRT N/A
- EPS
- LENZ N/A
- ESRT 0.24
- Revenue
- LENZ $5,000,000.00
- ESRT $763,746,000.00
- Revenue This Year
- LENZ N/A
- ESRT $2.27
- Revenue Next Year
- LENZ $285.82
- ESRT $3.04
- P/E Ratio
- LENZ N/A
- ESRT $33.36
- Revenue Growth
- LENZ N/A
- ESRT 1.14
- 52 Week Low
- LENZ $16.54
- ESRT $6.56
- 52 Week High
- LENZ $50.40
- ESRT $11.43
- Technical
- Relative Strength Index (RSI)
- LENZ 33.24
- ESRT 64.66
- Support Level
- LENZ $30.66
- ESRT $7.10
- Resistance Level
- LENZ $42.98
- ESRT $7.46
- Average True Range (ATR)
- LENZ 3.10
- ESRT 0.22
- MACD
- LENZ -1.51
- ESRT 0.07
- Stochastic Oscillator
- LENZ 7.69
- ESRT 100.00
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.